WinstonWınston
Back
Hofseth BioCare ASA logo

Hofseth BioCare ASA

HBC.OL
14
Packaged Foods · Consumer Defensive
Price
kr 1.34
+0.03 (+2.28%)
Market Cap
kr 552.8M
Exchange
Oslo Stock Exchange
Winston Score
14
Winston is worried
Weak fundamentals across most pillars.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Weak
Growth
Weak
Cash Flow
Weak
Stability
Data not available
Valuation
Data not available

Share count rising — dilution

+14.9% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 357.8M (2021) → 411.1M (2025)

Winston Score History

The full picture

Hofseth BioCare is a Norwegian company that turns leftover salmon parts — bones, skin, and organs — into health ingredients. Its main products include salmon oil rich in omega-3 fatty acids, protein hydrolysates, and calcium powders, which it sells to food, supplement, and pharmaceutical companies. The company is part of Norway's large salmon farming industry and positions itself as a sustainable ingredient supplier by using fish waste that would otherwise be discarded.

The company earns revenue by selling these ingredients in bulk to business customers, rather than selling directly to consumers. It operates primarily in Norway but sells to international markets, including Europe and Asia. Its competitive edge comes from its patented low-temperature processing technology, which it claims preserves the quality of the ingredients better than standard methods. The key growth driver is rising global demand for omega-3 and marine protein products, but with an operating margin of around -44%, the company must significantly grow sales volume to reach profitability.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-7.8% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+7.2% YoY

YoY Growth Rate

Slow EPS growth

R&D Spend

kr 0/ year

Declining (-100% vs prior year)

0.0% of revenue

Below sector average (18%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

49.9%ownership

Declining

Insider ownership declining — could be dilution or selling

Cash Runway

~4 years

kr 154M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

kr 154M cash & investments at current burn rate

Revenue declining

Hofseth BioCare ASA's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
6.1%
Thin — 6.1% gross margin
Profit after running costs
Operating Margin
-20.4%
Losing money on operations — -20.4%
Return on the money invested
ROCE
-4.2%
Weak — -4.2% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-9.3%
Shrinking sales (-9.3% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
3/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
-15.6%
Burning cash (-15.6%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
N/A
Data not available
Covers its interest
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial